Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory
Abstract
Depression is frequently associated with cognitive disturbances. Vortioxetine is a multimodal acting antidepressant that functions as a 5-HT3 and 5-HT7 and 5-HT1D receptor antagonist, 5-HT1B receptor partial agonist, 5-HT1A receptor agonist and inhibitor of the 5-HT transporter. Given its pharmacological profile, the present study was undertaken to determine whether vortioxetine could modulate several preclinical parameters known to be involved in cognitive processing. In the dorsal hippocampus of anaesthetized rats, the high-frequency stimulation of the Schaffer collaterals provoked a stable long-term potentiation (LTP) of ~25%. Interestingly, vortioxetine (10mg/kg, i.p.) counteracted the suppressant effect of elevated platform stress on hippocampal LTP induction. In the novel object recognition test, vortioxetine (10mg/kg, i.p.) increased the time spent exploring the novel object during the retention test and this pro-cognitive effect was prevented by the partial 5-HT3 receptor agonist SR57227 (1mg/kg, i.p.). Finally, compared to fluoxetine, sustained administration of vortioxetine (5mg/kg/day, s.c.) induced a rapid increase of cell proliferation in the hippocampal dentate gyrus. In summary, vortioxetine prevented the effect of stress on hippocampal LTP, increased rapidly hippocampal cell proliferation and enhanced short-term episodic memory, via, at least in part, its 5-HT3 receptor antagonism. Taken together, these preclinical data suggest that the antidepressant vortioxetine may have a beneficial effect on human cognitive processes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies found that Vortioxetine enhances LTP and long-lasting changes in hippocampal synaptic functions; it also stimulates neurogenesis, increases dendritic length, and promotes neuronal neurotransmission and synaptic neuroplasticity in this brain region.
“Studies found that Vortioxetine enhances LTP and long-lasting changes in hippocampal synaptic functions; it also stimulates neurogenesis, increases dendritic length, and promotes neuronal neurotransmission and synaptic neuroplasticity in this brain region.11”
Cites
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · see citing works
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166 · see citing works
Azmitia, E. C., & Segal, M. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,908 · see citing works
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · see citing works
A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
Vertes, R. P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130409 · Cited by 842 · see citing works
The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents
Dere, E., Huston, J. P., & Silva, M. A. D. S. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.01.005 · Cited by 669 · see citing works
Depression: a case of neuronal life and death?
Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 612 · see citing works
Bang-Andersen, B., Ruhland, T., Jørgensen, M., Smith, G., Frederiksen, K., Jensen, K. G., Zhong, H., Nielsen, S. M., Hogg, S., Mørk, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101459g · Cited by 606 · see citing works
Assessing rodent hippocampal involvement in the novel object recognition task. A review
Cohen, S. J., & Stackman, R. W. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.002 · Cited by 595 · see citing works
Conradi, H. J., Ormel, J., & de Jonge, P. (2011) · Psychological Medicine · doi:10.1017/s0033291710001911 · Cited by 515 · see citing works
Behavioural stress facilitates the induction of long-term depression in the hippocampus
Xu, L., Anwyl, R., & Rowan, M. J. (1997) · Nature · doi:10.1038/387497a0 · Cited by 509 · see citing works
Cognitive functioning in major depression – a summary
Hammar, Å. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.026.2009 · Cited by 491 · see citing works
Cognitive impairment in major depression
Marazziti, D., Consoli, G., Picchetti, M., Carlini, M., & Faravelli, L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.046 · Cited by 448 · see citing works
Katona, C., Hansen, T., & Olsen, C. K. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283542457 · Cited by 445 · cited 1× · see citing works
“Interestingly, in both preclinical and clinical studies of MDD, vortioxetine has shownpositive effects against cognitive dysfunction (Adell, 2010; Alvarez et al., 2012; du Jardin et al., 2014; Katona et al., 2012; Mørk et al., 2012, 2013).”
Behavioral stress modifies hippocampal plasticity through N-methyl-D-aspartate receptor activation.
Kim, J. J., Foy, M. R., & Thompson, R. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4750 · Cited by 435 · see citing works
Role of serotonin in memory impairment.
Buhot, M.-C., Martin, S., & Segu, L. (2000) · Annals of Medicine · doi:10.3109/07853890008998828 · Cited by 419 · see citing works
The role of cognitive impairment in general functioning in major depression
Baune, B. T., Miller, R., McAfoose, J., Johnson, M., Quirk, F., & Mitchell, D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.001 · Cited by 378 · see citing works
Serotonin receptors in cognitive behaviors.
Buhot, M. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80013-x · Cited by 329 · see citing works
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
Banasr, M., Soumier, A., Hery, M., Mocaër, E., & Daszuta, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.025 · Cited by 318 · see citing works
Acute Stress-induced Changes in Hippocampal/Prefrontal Circuits in Rats: Effects of Antidepressants
Rocher, C. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg122 · Cited by 307 · see citing works
A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory
King, M. V., Marsden, C. A., & Fone, K. C. F. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.001 · Cited by 305 · see citing works
Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats
Mørk, A., Montezinho, L. P., Miller, S., Trippodi-Murphy, C., Plath, N., Li, Y., Gulinello, M. E., & Sánchez, C. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.019 · Cited by 298 · see citing works
Self-citationPrefrontal Cortical Dysfunction in Depression Determined by Wisconsin Card Sorting Test Performance
Merriam, E. P., Thase, M. E., Haas, G. L., Keshavan, M. S., & Sweeney, J. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.780 · Cited by 278 · see citing works
Mørk, A., Pehrson, A., Brennum, L. T., Nielsen, S. M., Zhong, H., Lassen, A. B., Miller, S., Westrich, L., Boyle, N. J., Sánchez, C., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189068 · Cited by 271 · see citing works
Self-citationGorwood, P. A. P. M., Corruble, E., Falissard, B., & Goodwin, G. M. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07040574 · Cited by 254 · see citing works
Xu, L., Hölscher, C., Anwyl, R., & Rowan, M. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.6.3204 · Cited by 248 · see citing works
Staubli, U., & Xu, F.-B. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02445.1995 · Cited by 233 · see citing works
Long-term potentiation and memory
Morris, R. G. M. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1230 · Cited by 232 · see citing works
Alvarez, E., Perez, V., Dragheim, M., Loft, H., & Artigas, F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001027 · Cited by 225 · see citing works
Tanti, A., & Belzung, C. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.017 · Cited by 220 · see citing works
Winters, B. D., & Bussey, T. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0480-05.2005 · Cited by 214 · see citing works
Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions
Bartolini, L., Casamenti, F., & Pepeu, G. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02021-7 · Cited by 193 · see citing works
The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates
Barnes, J. M., Costall, B., Coughlan, J., Domeney, A. M., Gerrard, P. A., Kelly, M. E., Naylor, R. J., Onaivi, E. S., Tomkins, D. M., & Tyers, M. B. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90385-u · Cited by 193 · see citing works
Shakesby, A. C., Anwyl, R., & Rowan, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03638.2002 · Cited by 173 · see citing works
Bertaina‐Anglade, V., Enjuanes, E., Morillon, D., & Rochelle, C. D. L. (2006) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2006.04.001 · Cited by 168 · see citing works
Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
Mnie‐Filali, O., Faure, C., Lambás‐Señas, L., Mansari, M. E., Belblidia, H., Gondard, E., Etiévant, A., Scarna, H., Didier, A., Bérod, A., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.13 · Cited by 158 · see citing works
Self-citationPehrson, A. L., Cremers, T., Bétry, C., van der Hart, M. G. C., Jørgensen, L., Madsen, M., Haddjeri, N., Ebert, B., & Sanchez, C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.006 · Cited by 155 · see citing works
Self-citationEgeland, J., Rund, B. R., Sundet, K. S., Landrø, N. I., Asbjørnsen, A. E., Lund, A., Roness, A., Stordal, K. I., & Hugdahl, K. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00146.x · Cited by 150 · see citing works
Basso, M. R., & Bornstein, R. A. (1999) · Neuropsychology · doi:10.1037/0894-4105.13.4.557 · Cited by 141 · cited 1× · see citing works
“…episodes of major depression impair memory (Gorwood et al., 2008) and a correlation between depression severity and the magnitude of cognitive deficits has been reported in a population of young adult depressed patients (Basso and Bornstein, 1999; Egeland et al., 2003; Merriam et al., 1999).”
Corradetti, R., Ballerini, L., Pugliese, A. M., & Pepeu, G. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90140-w · Cited by 141 · see citing works
du Jardin, K. G., Jensen, J. B., Sanchez, C., & Pehrson, A. L. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.07.001 · Cited by 133 · see citing works
Self-citationBasso, M. R., & Bornstein, R. A. (1999) · Neuropsychology · doi:10.1037//0894-4105.13.4.557 · Cited by 128 · see citing works
Henningsen, K., Andreasen, J. T., Bouzinova, E. V., Jayatissa, M. N., Jensen, M. S., Redrobe, J. P., & Wiborg, O. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.039 · Cited by 125 · see citing works
Serotonin receptor expression along the dorsal–ventral axis of mouse hippocampus
Tanaka, K. F., Samuels, B. A., & Hen, R. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0038 · Cited by 124 · see citing works
Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression
Gómez‐Galán, M., Bundel, D. D., Eeckhaut, A. V., Smolders, I. J., & Lindskog, M. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.10 · Cited by 121 · see citing works
Guilloux, J., Mendez‐David, I., Pehrson, A. L., Guiard, B. P., Repérant, C., Orvoën, S., Gardier, A. M., Hen, R., Ebert, B., Miller, S., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.014 · Cited by 117 · see citing works
Self-citationObject recognition testing: Rodent species, strains, housing conditions, and estrous cycle
van Goethem, N. P., Rutten, K., van der Staay, F. J., Jans, L. A. W., Akkerman, S., Steinbusch, H. W. M., Blokland, A., Klooster, J. G. L. T., & Prickaerts, J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.023 · Cited by 115 · see citing works
Meneses, A. (2003) · Learning & Memory · doi:10.1101/lm.60503 · Cited by 112 · see citing works
Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial
Akhondzadeh, S., Mohammadi, N., Noroozıan, M., Karamghadiri, N., Ghoreishi, A., Jamshidi, A. H., & Forghani, S. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.004 · Cited by 109 · see citing works
Czachura, J. F., & Rasmussen, K. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000290 · Cited by 97 · see citing works
Jensen, J. B., du Jardin, K. G., Song, D., Budac, D., Smagin, G., Sanchez, C., & Pehrson, A. L. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.011 · Cited by 96 · cited 2× · see citing works
“Using this task, it was also recently reported that the SSRI escitalopram and the SNRI duloxetine failed to restore 5-HT depletioninduced deficits in the object recognition at doses corresponding to full SERT occupancy whereas vortioxetine was active, suggesting that vortioxetine's receptor activities contributes to i…”
Self-citationDale, E., Zhang, H., Leiser, S. C., Xiao, Y., Lu, D., Yang, C. R., Plath, N., & Sanchez, C. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114543719 · Cited by 93 · see citing works
Self-citationQi, H., Mailliet, F., Spedding, M., Rocher, C., Zhang, X., Delagrange, P., McEwen, B. S., Jay, T. M., & Svenningsson, P. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.068 · Cited by 91 · see citing works
Felice, D. F., O'Leary, O., Pizzo, R., & Cryan, J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.066 · Cited by 70 · see citing works
Areberg, J., Luntang‐Jensen, M., Søgaard, B., & Nilausen, D. Ø. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00810.x · Cited by 68 · see citing works
The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys
Arnsten, A. F. T., Lin, C. H., van Dyck, C. H., & Stanhope, K. J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00162-5 · Cited by 66 · see citing works
Howland, J. G., & Cazakoff, B. N. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.10.006 · Cited by 65 · see citing works
Leiser, S. C., Pehrson, A. L., Robichaud, P. J., & Sánchez, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12782 · Cited by 63 · see citing works
Self-citationBetry, C., Pehrson, A. L., Etiévant, A., Ebert, B., Sánchez, C., & Haddjeri, N. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001058 · Cited by 62 · see citing works
Self-citationPotentials evoked by alvear tract in hippocampal CA1 region of rats. II. Spatial field analysis
Leung, S. W. (1979) · Journal of Neurophysiology · doi:10.1152/jn.1979.42.6.1571 · Cited by 62 · see citing works
Cazakoff, B. N., & Howland, J. G. (2009) · Hippocampus · doi:10.1002/hipo.20738 · Cited by 58 · see citing works
Bertaina‐Anglade, V., Rochelle, C. D. L., Mocaër, E., & Seguin, L. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.015 · Cited by 58 · see citing works
Ondansetron improves cognitive performance in the Morris water maze spatial navigation task
Fontana, D., Daniels, S. E., Henderson, C., Eglen, R. M., & Wong, E. H. F. (1995) · Psychopharmacology · doi:10.1007/bf02245812 · Cited by 58 · see citing works
Meneses, A., & Hong, E. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00002-x · Cited by 58 · see citing works
The Importance of Cognitive Phenotypes in Experimental Modeling of Animal Anxiety and Depression
Kalueff, A. V., & Murphy, D. L. (2007) · Neural Plasticity · doi:10.1155/2007/52087 · Cited by 56 · see citing works
Kojima, T., Matsumoto, M., Togashi, H., Tachibana, K., Kemmotsu, O., & Yoshioka, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03756-3 · Cited by 56 · see citing works
Abrial, E., Bétourné, A., Etiévant, A., Lucas, G., Scarna, H., Lambás‐Señas, L., & Haddjeri, N. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu031 · Cited by 53 · see citing works
Self-citationCaudal, D., Jay, T., & Godsil, B. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00019 · Cited by 50 · see citing works
Hodges, H. R., Sowinski, P., Turner, J. J., & Fletcher, A. (1996) · Psychopharmacology · doi:10.1007/bf02249414 · Cited by 49 · see citing works
Passani, M. B., Pugliese, A. M., Azzurrini, M., & Corradetti, R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13132.x · Cited by 49 · see citing works
Mnie‐Filali, O., Mansari, M. E., Espana, A., Sánchez, C., & Haddjeri, N. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.044 · Cited by 45 · see citing works
Self-citationPersistent inhibition of hippocampal long‐term potentiation in vivo by learned helplessness stress
Ryan, B. K., Vollmayr, B., Klyubin, I. V., Gass, P., & Rowan, M. J. (2009) · Hippocampus · doi:10.1002/hipo.20677 · Cited by 45 · see citing works
Cooke, J. D., Grover, L. M., & Spangler, P. R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.037 · Cited by 42 · see citing works
Miyata, S., Shimoi, T., Hirano, S., Yamada, N., Hata, Y., Yoshikawa, N., Ohsawa, M., & Kamei, J. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070314 · Cited by 37 · see citing works
Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.
Adell, A. (2010) · PubMed · Cited by 34 · see citing works
Li, C., Huang, P., Lü, Q., Zhou, M. L., Guo, L., & Xu, X. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.009 · Cited by 33 · see citing works
R-citalopram prevents the neuronal adaptive changes induced by escitalopram
Mnie‐Filali, O., Faure, C., Mansari, M. E., Lambás‐Señas, L., Bérod, A., Zimmer, L., Sánchez, C., & Haddjeri, N. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f04047 · Cited by 33 · see citing works
Self-citationMatsumoto, M., Tachibana, K., Togashi, H., Tahara, K., Kojima, T., Yamaguchi, T., & Yoshioka, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2094-1 · Cited by 32 · see citing works
Pitsikas, N., & Borsini, F. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00586-9 · Cited by 22 · see citing works
Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
Roychoudhury, M., & Sk, K. (1997) · PubMed · Cited by 20 · see citing works
Involvement of 5-HT receptors in learning and memory.
Roman, F. S., & Marchetti, E. (1998) · PubMed · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
<p>Cognitive impairment in depression: recent advances and novel treatments</p>
Perini, G., Cotta Ramusino, M., Sinforiani, E., Bernini, S., Petrachi, R., & Costa, A. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s199746 · Cited by 384 · see citing works
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Dale, E., Bang‐Andersen, B., & Sánchez, C. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.03.011 · Cited by 238 · see citing works
Self-citationDale, E., Pehrson, A. L., Jeyarajah, T., Li, Y., Leiser, S. C., Smagin, G. N., Olsen, C. K., & Sánchez, C. (2015) · CNS Spectrums · doi:10.1017/s1092852915000425 · Cited by 152 · see citing works
Self-citationMa, J., Wang, R., Chen, Y., Wang, Z., & Dong, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02693-1 · Cited by 142 · see citing works
Lu, Y., Ho, C. S. H., McIntyre, R. S., Wang, W., & Ho, R. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.007 · Cited by 90 · see citing works
Riga, M. S., Sánchez, C., Celada, P., & Artigas, F. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.023 · Cited by 88 · see citing works
Self-citationZinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity
Doboszewska, U., Właź, P., Nowak, G., Radziwoń-Zaleska, M., Cui, R., & Młyniec, K. (2017) · Neural Plasticity · doi:10.1155/2017/3682752 · Cited by 89 · see citing works
Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant
Sowa-Kućma, M., Pańczyszyn-Trzewik, P., Misztak, P., Jaeschke, R. R., Sendek, K., Styczeń, K., Datka, W., & Koperny, M. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.030 · Cited by 83 · see citing works
Vortioxetine for cognitive enhancement in major depression: From animal models to clinical research
Bennabi, D., Haffen, E., & Van Waes, V. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00771 · Cited by 75 · see citing works
“(17)], this improvement was observed through a neurogenesisindependent mechanism.”
BackgroundMethodInfluentialBruno, V., Caraci, F., Copani, A., Matrisciano, F., Nicoletti, F., & Battaglia, G. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.044 · Cited by 71 · see citing works
Effects of 5-HT-7 receptor ligands on memory and cognition
Zareifopoulos, N., & Papatheodoropoulos, C. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.10.011 · Cited by 40 · see citing works
Zwamborn, R. A. J., Snijders, C., An, N., Thomson, A. C., Rutten, B. P. F., & de Nijs, L. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.04.005 · Cited by 39 · see citing works
Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients
Dvojkovic, A., Perković, M. N., Šagud, M., Erjavec, G. N., Peleš, A. M., Štrac, D. Š., Ćusa, B. V., Tudor, L., Kušević, Z., Konjevod, M., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110016 · Cited by 37 · see citing works
Xue, S., Xue, F., Ma, Q., Wang, S., Wang, Y., Tan, Q., Wang, H., Zhou, C., & Peng, Z. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172738 · Cited by 35 · see citing works
Mishra, A., & Goel, R. K. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.10.010 · Cited by 34 · see citing works
Alboni, S., Benatti, C., Colliva, C., Radighieri, G., Blom, J. M. C., Brunello, N., & Tascedda, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.603979 · Cited by 28 · see citing works
Ishikawa, T., Okano, M., Minami, A., Tsunekawa, H., Satoyoshi, H., Tsukamoto, Y., Takahata, K., & Muraoka, S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.10.032 · Cited by 27 · see citing works
Dale, E., Grunnet, M., Pehrson, A. L., Frederiksen, K., Larsen, P. H., Nielsen, J., Stensbøl, T. B., Ebert, B., Yin, H., Lu, D., et al. (2017) · Brain Research · doi:10.1016/j.brainres.2017.12.025 · Cited by 27 · see citing works
Self-citationWaller, J. A., Chen, F., & Sánchez, C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.012 · Cited by 25 · see citing works
Self-citationJung, H. Y., Kim, D. W., Nam, S. M., Kim, J. W., Chung, J. Y., Won, M.-H., Seong, J. K., Yoon, Y. S., Yoo, D. Y., & Hwang, I. K. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.09.006 · Cited by 23 · see citing works
In vivo and in vitro effects of vortioxetine on molecules associated with neuroplasticity
Kugathasan, P., Waller, J. A., Westrich, L., Abdourahman, A., Tamm, J. A., Pehrson, A. L., Dale, E., Gulinello, M. E., Sánchez, C., & Li, Y. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116667710 · Cited by 22 · see citing works
Self-citationNicola, M. D., Pepe, M., Panaccione, I., Moccia, L., Dattoli, L., Molinaro, M., Sani, G., Janiri, L., & McIntyre, R. S. (2020) · CNS Spectrums · doi:10.1017/s109285292000173x · Cited by 22 · see citing works
Wang, Y., Gu, J., Liu, L., Liu, Y., Tang, W., Ji, C.-H., Guan, W., Zhao, X., Sun, Y., Xu, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.673221 · Cited by 20 · see citing works
Witt, N. A., Lee, B., Ghent, K., Zhang, W. Q., Pehrson, A. L., Sánchez, C., & Gould, G. G. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00386 · Cited by 20 · see citing works
Self-citationSerotonin and exercise-induced brain plasticity
(2015) · Neurotransmitter · doi:10.14800/nt.793 · Cited by 18 · see citing works
Determination of vortioxetine in human serum and saliva samples by HPLC–DAD and HPLC–MS
Wróblewski, K., Petruczynik, A., Buszewski, B., Szultka‐Młyńska, M., Karakuła‐Juchnowicz, H., & Waksmundzka‐Hajnos, M. (2016) · Acta Chromatographica · doi:10.1556/1326.2017.29.3.02 · Cited by 16 · see citing works
Wang, L., He, Z., Zhu, Z., Yuan, W., Cai, W., Li, L., Zhang, J., Hou, W., Yang, Y., Zhang, X., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109704 · Cited by 16 · see citing works
Riga, M. S., Sánchez, C., Celada, P., & Artigas, F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108238 · Cited by 14 · see citing works
Self-citationChemogenetic activation of prefrontal astroglia enhances recognition memory performance in rat
Delcourte, S., Bouloufa, A., Rovera, R., Betry, C., Abrial, E., Dkhissi‐Benyahya, O., Heinrich, C., Marcy, G., Raineteau, O., Haddjeri, N., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115384 · Cited by 13 · see citing works
Self-citationTanaka, T., Ago, Y., Umehara, C., Imoto, E., Hasebe, S., Hashimoto, H., Takuma, K., & Matsuda, T. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw115 · Cited by 13 · see citing works
the ILDE Study Group, Fattori, A., Neri, L., Bellomo, A., Vaggi, M., & Mencacci, C. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1595-4 · Cited by 12 · see citing works
Neshan, M., Campbell, A., Malakouti, S. K., Zareei, M., & Ahangari, G. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04716 · Cited by 12 · see citing works
Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent Mechanism
Felice, D., Guilloux, J., Pehrson, A. L., Li, Y., Mendez‐David, I., Gardier, A. M., Sánchez, C., & David, D. J. P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00204 · Cited by 12 · see citing works
Self-citationMurthy, M. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.009 · Cited by 10 · see citing works
Hariom, Kumari, P., Chaturvedi, S., Shrivastav, S., Maratha, S. R., & Walia, V. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173930 · Cited by 9 · see citing works
Use of vortioxetine in different neurological fields: a systematic review and future perspectives
Verrienti, G., Colonna, I., & Raccagni, C. (2025) · Neurological Sciences · doi:10.1007/s10072-025-07987-1 · Cited by 9 · see citing works
Propriétés pharmacologiques de la vortioxetine et leurs conséquences pré-cliniques
David, D. J. P., Tritschler, L., Guilloux, J., Gardier, A. M., Sánchez, C., & Raphaël Gaillard, B. (2016) · L Encéphale · doi:10.1016/s0013-7006(16)30015-x · Cited by 8 · see citing works
Self-citationNewman‐Tancredi, A., Depoortère, R., Carilla-Durand, E., Tarayre, J. P., Kleven, M. S., Koek, W., Bardin, L., & Varney, M. A. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.11.002 · Cited by 7 · see citing works
Anhedonia as a basic syndrome and a target for treatment for depressive disorder
Mazo, G. E., & Kibitov, A. O. (2019) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2019-3-10-18 · Cited by 7 · see citing works
Yu, Y., Li, J., He, X., Lai, Z., Hao, R., Qi, Y., Cao, D., Fu, M., Ma, H., Xie, Q., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15793 · Cited by 6 · see citing works
Vortioxetine improved social and cognitive deficits in acute ketamine model of schizophrenia in rats
Ünal, G., & Taşkıran, M. (2020) · Journal of Research in Pharmacy · doi:10.35333/jrp.2020.220 · Cited by 6 · see citing works
Antistress and antidepressant properties of dapoxetine and vortioxetine
Ratajczak, P., Kus, K., Zielińska‐Przyjemska, M., Skórczewska, B., Zaprutko, T., Kopciuch, D., Paczkowska, A., & Nowakowska, E. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-020 · Cited by 6 · see citing works
Yücel, N. T., Kandemir, Ü., Üçel, U. İ., Özkay, Ü. D., & Can, Ö. D. (2023) · Biomedicines · doi:10.3390/biomedicines11041137 · Cited by 6 · see citing works
Laursen, B., Bundgaard, C. H., Graversen, C., Grupe, M., Sánchez, C., Leiser, S. C., Sørensen, H. B. D., Drewes, A. M., & Bastlund, J. F. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.024 · Cited by 6 · see citing works
Self-citationSchweimer, J. V., Brouard, J. T., Li, Y., Sánchez, C., & Sharp, T. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15623 · Cited by 6 · see citing works
Self-citationHjorth, S. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116647621 · Cited by 5 · see citing works
Novel Object Recognition Test in Rodents:
Bouët, V., Fréret, T., Schumann‐Bard, P., & Boulouard, M. (2018) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-812012-5.00027-6 · Cited by 4 · see citing works
Ye, X., Xu, P., Jiao, J., Zhao, H., Jin, K., Zhang, S., Pan, F., Chen, J., Jiang, H., Hu, J., et al. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s491768 · Cited by 3 · see citing works
Dell’Osso, B. M., Blasi, G., Serafini, G., Serrati, C., Bianchetti, A., Porto, I., Forleo, G. B., Pugliese, A., Mastrostefano, A., & Nicoletti, F. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2602193 · Cited by 3 · see citing works
Stable rat models in constipation with depression and anxiety: evaluation and validation
Liu, J., Li, S., Bian, C., Mi, H., He, T., Qian, H., & Zhang, D. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1745331 · Cited by 3 · see citing works
Taşkıran, M., Taskiran, S. Y., Ünal, G., Bozkurt, N. M., & Gölgeli, A. (2024) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.13028 · Cited by 3 · see citing works
Bang‐Andersen, B., Olsen, C. K., & Sánchez, C. (2016) · doi:10.1002/9783527800315.ch9 · Cited by 3 · see citing works
Self-citationTaşkıran, A. Ş., & Filiz, A. K. (2024) · Neurochemical Journal · doi:10.1134/s1819712424700478 · Cited by 1 · see citing works
The Effects And Possible Mechanisms of Vortioxetine on Pentylenetetrazole-Induced Seizures In RatsPreprint
Taşkıran, A. Ş., & Filiz, A. K. (2021) · Research Square · doi:10.21203/rs.3.rs-805264/v1
Watanabe, K., Sumiyoshi, T., Kato, M., Kikuchi, T., Moriguchi, Y., Åström, D. O., & Christensen, M. C. (2025) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2025.100955
Ma, J., Wang, R., Chen, Y., Wang, Z., & Dong, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26566064
Ma, J., Wang, R., Chen, Y., Wang, Z., & Dong, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26566061
Hepatic Inflammation and Apoptosis in Socially Isolated Rats: Effects of Vortioxetine Treatment
Arı, N. S., Akkuş, M., Solak, H., Koca, R. Ö., & GÖRMÜŞ, İ. S. (2026) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-170887
Xu, H., Fan, H., Ding, E.-H., Hou, P., Jiang, B., & Zhu, W.-B. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1837566
- Authors
- Bétry, C., Etiévant, A., Pehrson, A., Sánchez, C., & Haddjeri, N.
- Affiliations
- Lyon 1 Université (FR)
- Lundbeck (United States) (US)
- Corresponding author
- Haddjeri, Nasser
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 58
- Pages
- 38-46
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W1988262692
- Cited by
- 59
- References
- 81
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 6 · 2019: 6 · 2018: 5 · 2017: 7 · 2016: 10 · 2015: 4
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Université Claude Bernard Lyon 1
- Université de Lyon
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- vortioxetine, multimodal antidepressant, hippocampal long-term potentiation, 5-HT3 receptor antagonism, 5-HT7 receptor, 5-HT1A receptor, 5-HT1B receptor, 5-HT transporter, novel object recognition, episodic memory, fluoxetine
- MeSH terms
- Vortioxetine, Animals, Antidepressive Agents, Exploratory Behavior, Fluoxetine, Hippocampus, Male, Memory, Short-Term, Piperazines, Stress, Psychological, Sulfides, Cohort Studies, RNA-Binding Proteins, Rats, Sprague-Dawley, Long-Term Potentiation, Excitatory Postsynaptic Potentials, Recognition, Psychology, Receptors, Serotonin, 5-HT3, Cell Proliferation, Serotonin 5-HT3 Receptor Antagonists, Memory, Episodic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review